APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antiviral Drug Packaging

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antiviral Drug Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173928840326 December 2025195 pages

Choose your research edition.

Industry ResearchAntiviral Drug Packaging Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiviral Drug Packaging Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antiviral Drug Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiviral Drug Packaging Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiviral Drug Packaging Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antiviral Drug Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiviral Drug Packaging include Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF and Lonza, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antiviral Drug Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiviral Drug Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiviral Drug Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiviral Drug Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiviral Drug Packaging Segment by Company

Avery Dennison Corporation

E.I. du Pont de Nemours

CCL Industries Inc

BioCote

Avient

Mondi

Biomaster

BASF

Lonza

Takex Labo Co. Ltd

Berry

Lageen Tubes.

Antiviral Drug Packaging Segment by Type

Rigid Plastic

Flexible Blister Foils

Others

Antiviral Drug Packaging Segment by Application

Pharmaceuticals

Healthcare

Antiviral Drug Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiviral Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiviral Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiviral Drug Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antiviral Drug Packaging market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antiviral Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antiviral Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antiviral Drug Packaging Industry Trends Table 2. Antiviral Drug Packaging Industry Drivers Table 3. Antiviral Drug Packaging Industry Opportunities and Challenges Table 4. Antiviral Drug Packaging Industry Restraints Table 5. Global Antiviral Drug Packaging Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antiviral Drug Packaging Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antiviral Drug Packaging Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Antiviral Drug Packaging Sales Market Share by Manufacturers Table 9. Global Antiviral Drug Packaging Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Antiviral Drug Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antiviral Drug Packaging Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antiviral Drug Packaging Manufacturers, Product Type & Application Table 13. Global Antiviral Drug Packaging Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antiviral Drug Packaging by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rigid Plastic Table 17. Major Manufacturers of Flexible Blister Foils Table 18. Major Manufacturers of Others Table 19. Global Antiviral Drug Packaging Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Antiviral Drug Packaging Sales by Type (2021-2026) & (k units) Table 21. Global Antiviral Drug Packaging Sales by Type (2027-2032) & (k units) Table 22. Global Antiviral Drug Packaging Sales Market Share by Type (2021-2026) Table 23. Global Antiviral Drug Packaging Sales Market Share by Type (2027-2032) Table 24. Global Antiviral Drug Packaging Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Antiviral Drug Packaging Revenue by Type (2021-2026) & (k units) Table 26. Global Antiviral Drug Packaging Revenue by Type (2027-2032) & (k units) Table 27. Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2026) Table 28. Global Antiviral Drug Packaging Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmaceuticals Table 30. Major Manufacturers of Healthcare Table 31. Global Antiviral Drug Packaging Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Antiviral Drug Packaging Sales by Application (2021-2026) & (k units) Table 33. Global Antiviral Drug Packaging Sales by Application (2027-2032) & (k units) Table 34. Global Antiviral Drug Packaging Sales Market Share by Application (2021-2026) Table 35. Global Antiviral Drug Packaging Sales Market Share by Application (2027-2032) Table 36. Global Antiviral Drug Packaging Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Antiviral Drug Packaging Revenue by Application (2021-2026) & (k units) Table 38. Global Antiviral Drug Packaging Revenue by Application (2027-2032) & (k units) Table 39. Global Antiviral Drug Packaging Revenue Market Share by Application (2021-2026) Table 40. Global Antiviral Drug Packaging Revenue Market Share by Application (2027-2032) Table 41. Global Antiviral Drug Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Antiviral Drug Packaging Sales by Region (2021-2026) & (k units) Table 43. Global Antiviral Drug Packaging Sales Market Share by Region (2021-2026) Table 44. Global Antiviral Drug Packaging Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Antiviral Drug Packaging Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 48. North America Antiviral Drug Packaging Sales by Country (2027-2032) & (k units) Table 49. Europe Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 51. Europe Antiviral Drug Packaging Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Antiviral Drug Packaging Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Antiviral Drug Packaging Sales by Country (2027-2032) & (k units) Table 58. Global Antiviral Drug Packaging Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antiviral Drug Packaging Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Antiviral Drug Packaging Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Antiviral Drug Packaging Revenue Market Share by Region (2021-2026) Table 62. Global Antiviral Drug Packaging Revenue Market Share by Region (2027-2032) Table 63. Avery Dennison Corporation Company Information Table 64. Avery Dennison Corporation Business Overview Table 65. Avery Dennison Corporation Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio Table 67. Avery Dennison Corporation Recent Development Table 68. E.I. du Pont de Nemours Company Information Table 69. E.I. du Pont de Nemours Business Overview Table 70. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio Table 72. E.I. du Pont de Nemours Recent Development Table 73. CCL Industries Inc Company Information Table 74. CCL Industries Inc Business Overview Table 75. CCL Industries Inc Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CCL Industries Inc Antiviral Drug Packaging Product Portfolio Table 77. CCL Industries Inc Recent Development Table 78. BioCote Company Information Table 79. BioCote Business Overview Table 80. BioCote Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BioCote Antiviral Drug Packaging Product Portfolio Table 82. BioCote Recent Development Table 83. Avient Company Information Table 84. Avient Business Overview Table 85. Avient Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Avient Antiviral Drug Packaging Product Portfolio Table 87. Avient Recent Development Table 88. Mondi Company Information Table 89. Mondi Business Overview Table 90. Mondi Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mondi Antiviral Drug Packaging Product Portfolio Table 92. Mondi Recent Development Table 93. Biomaster Company Information Table 94. Biomaster Business Overview Table 95. Biomaster Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Biomaster Antiviral Drug Packaging Product Portfolio Table 97. Biomaster Recent Development Table 98. BASF Company Information Table 99. BASF Business Overview Table 100. BASF Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. BASF Antiviral Drug Packaging Product Portfolio Table 102. BASF Recent Development Table 103. Lonza Company Information Table 104. Lonza Business Overview Table 105. Lonza Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lonza Antiviral Drug Packaging Product Portfolio Table 107. Lonza Recent Development Table 108. Takex Labo Co. Ltd Company Information Table 109. Takex Labo Co. Ltd Business Overview Table 110. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio Table 112. Takex Labo Co. Ltd Recent Development Table 113. Berry Company Information Table 114. Berry Business Overview Table 115. Berry Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Berry Antiviral Drug Packaging Product Portfolio Table 117. Berry Recent Development Table 118. Lageen Tubes. Company Information Table 119. Lageen Tubes. Business Overview Table 120. Lageen Tubes. Antiviral Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Lageen Tubes. Antiviral Drug Packaging Product Portfolio Table 122. Lageen Tubes. Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Antiviral Drug Packaging Distributors List Table 126. Antiviral Drug Packaging Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Antiviral Drug Packaging Product Image Figure 2. Global Antiviral Drug Packaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiviral Drug Packaging Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiviral Drug Packaging Sales (2021-2032) & (k units) Figure 5. Global Antiviral Drug Packaging Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antiviral Drug Packaging Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rigid Plastic Image Figure 9. Flexible Blister Foils Image Figure 10. Others Image Figure 11. Global Antiviral Drug Packaging Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Antiviral Drug Packaging Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Antiviral Drug Packaging Sales Market Share by Type (2021-2032) Figure 14. Global Antiviral Drug Packaging Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Antiviral Drug Packaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2032) Figure 17. Pharmaceuticals Image Figure 18. Healthcare Image Figure 19. Global Antiviral Drug Packaging Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Antiviral Drug Packaging Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antiviral Drug Packaging Sales Market Share by Application (2021-2032) Figure 22. Global Antiviral Drug Packaging Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Antiviral Drug Packaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Antiviral Drug Packaging Revenue Market Share by Application (2021-2032) Figure 25. North America Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Antiviral Drug Packaging Sales Market Share by Country (2021-2032) Figure 27. U.S. Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Antiviral Drug Packaging Sales Market Share by Country (2021-2032) Figure 32. Germany Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Antiviral Drug Packaging Sales Market Share by Country (2021-2032) Figure 39. China Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Antiviral Drug Packaging Sales Market Share by Country (2021-2032) Figure 47. Brazil Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Antiviral Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Antiviral Drug Packaging Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Antiviral Drug Packaging Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Antiviral Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 58. North America Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antiviral Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 60. Europe Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antiviral Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Antiviral Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Antiviral Drug Packaging Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Antiviral Drug Packaging Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Rigid Plastic
  • Flexible Blister Foils
  • Others
Applications
  • Pharmaceuticals
  • Healthcare
Companies covered
  • Avery Dennison Corporation
  • E.I. du Pont de Nemours
  • CCL Industries Inc
  • BioCote
  • Avient
  • Mondi
  • Biomaster
  • BASF
  • Lonza
  • Takex Labo Co. Ltd
  • Berry
  • Lageen Tubes.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antiviral Drug Packaging Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antiviral Drug Packaging Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antiviral Drug Packaging Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antiviral Drug Packaging Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antiviral Drug Packaging Market Dynamics
  1. 2.1 Antiviral Drug Packaging Industry Trends
  2. 2.2 Antiviral Drug Packaging Industry Drivers
  3. 2.3 Antiviral Drug Packaging Industry Opportunities and Challenges
  4. 2.4 Antiviral Drug Packaging Industry Restraints
3 Antiviral Drug Packaging Market by Manufacturers
  1. 3.1 Global Antiviral Drug Packaging Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antiviral Drug Packaging Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antiviral Drug Packaging Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antiviral Drug Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiviral Drug Packaging Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antiviral Drug Packaging Manufacturers, Product Type & Application
  7. 3.7 Global Antiviral Drug Packaging Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiviral Drug Packaging Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiviral Drug Packaging Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiviral Drug Packaging Tier 1, Tier 2, and Tier 3
4 Antiviral Drug Packaging Market by Type
  1. 4.1 Antiviral Drug Packaging Type Introduction
  2. 4.1.1 Rigid Plastic
  3. 4.1.2 Flexible Blister Foils
  4. 4.1.3 Others
  5. 4.2 Global Antiviral Drug Packaging Sales by Type
  6. 4.2.1 Global Antiviral Drug Packaging Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antiviral Drug Packaging Sales by Type (2021-2032)
  8. 4.2.3 Global Antiviral Drug Packaging Sales Market Share by Type (2021-2032)
  9. 4.3 Global Antiviral Drug Packaging Revenue by Type
  10. 4.3.1 Global Antiviral Drug Packaging Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antiviral Drug Packaging Revenue by Type (2021-2032)
  12. 4.3.3 Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2032)
5 Antiviral Drug Packaging Market by Application
  1. 5.1 Antiviral Drug Packaging Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Healthcare
  4. 5.2 Global Antiviral Drug Packaging Sales by Application
  5. 5.2.1 Global Antiviral Drug Packaging Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antiviral Drug Packaging Sales by Application (2021-2032)
  7. 5.2.3 Global Antiviral Drug Packaging Sales Market Share by Application (2021-2032)
  8. 5.3 Global Antiviral Drug Packaging Revenue by Application
  9. 5.3.1 Global Antiviral Drug Packaging Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antiviral Drug Packaging Revenue by Application (2021-2032)
  11. 5.3.3 Global Antiviral Drug Packaging Revenue Market Share by Application (2021-2032)
6 Global Antiviral Drug Packaging Sales by Region
  1. 6.1 Global Antiviral Drug Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antiviral Drug Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Antiviral Drug Packaging Sales by Region (2021-2026)
  4. 6.2.2 Global Antiviral Drug Packaging Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antiviral Drug Packaging Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antiviral Drug Packaging Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antiviral Drug Packaging Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antiviral Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antiviral Drug Packaging Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antiviral Drug Packaging Revenue by Region
  1. 7.1 Global Antiviral Drug Packaging Revenue by Region
  2. 7.1.1 Global Antiviral Drug Packaging Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antiviral Drug Packaging Revenue by Region (2021-2026)
  4. 7.1.3 Global Antiviral Drug Packaging Revenue by Region (2027-2032)
  5. 7.1.4 Global Antiviral Drug Packaging Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antiviral Drug Packaging Revenue (2021-2032)
  8. 7.2.2 North America Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antiviral Drug Packaging Revenue (2021-2032)
  11. 7.3.2 Europe Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antiviral Drug Packaging Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antiviral Drug Packaging Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antiviral Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Avery Dennison Corporation
  2. 8.1.1 Avery Dennison Corporation Company Information
  3. 8.1.2 Avery Dennison Corporation Business Overview
  4. 8.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio
  6. 8.1.5 Avery Dennison Corporation Recent Developments
  7. 8.2 E.I. du Pont de Nemours
  8. 8.2.1 E.I. du Pont de Nemours Company Information
  9. 8.2.2 E.I. du Pont de Nemours Business Overview
  10. 8.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio
  12. 8.2.5 E.I. du Pont de Nemours Recent Developments
  13. 8.3 CCL Industries Inc
  14. 8.3.1 CCL Industries Inc Company Information
  15. 8.3.2 CCL Industries Inc Business Overview
  16. 8.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CCL Industries Inc Antiviral Drug Packaging Product Portfolio
  18. 8.3.5 CCL Industries Inc Recent Developments
  19. 8.4 BioCote
  20. 8.4.1 BioCote Company Information
  21. 8.4.2 BioCote Business Overview
  22. 8.4.3 BioCote Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioCote Antiviral Drug Packaging Product Portfolio
  24. 8.4.5 BioCote Recent Developments
  25. 8.5 Avient
  26. 8.5.1 Avient Company Information
  27. 8.5.2 Avient Business Overview
  28. 8.5.3 Avient Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Avient Antiviral Drug Packaging Product Portfolio
  30. 8.5.5 Avient Recent Developments
  31. 8.6 Mondi
  32. 8.6.1 Mondi Company Information
  33. 8.6.2 Mondi Business Overview
  34. 8.6.3 Mondi Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mondi Antiviral Drug Packaging Product Portfolio
  36. 8.6.5 Mondi Recent Developments
  37. 8.7 Biomaster
  38. 8.7.1 Biomaster Company Information
  39. 8.7.2 Biomaster Business Overview
  40. 8.7.3 Biomaster Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biomaster Antiviral Drug Packaging Product Portfolio
  42. 8.7.5 Biomaster Recent Developments
  43. 8.8 BASF
  44. 8.8.1 BASF Company Information
  45. 8.8.2 BASF Business Overview
  46. 8.8.3 BASF Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BASF Antiviral Drug Packaging Product Portfolio
  48. 8.8.5 BASF Recent Developments
  49. 8.9 Lonza
  50. 8.9.1 Lonza Company Information
  51. 8.9.2 Lonza Business Overview
  52. 8.9.3 Lonza Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lonza Antiviral Drug Packaging Product Portfolio
  54. 8.9.5 Lonza Recent Developments
  55. 8.10 Takex Labo Co. Ltd
  56. 8.10.1 Takex Labo Co. Ltd Company Information
  57. 8.10.2 Takex Labo Co. Ltd Business Overview
  58. 8.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio
  60. 8.10.5 Takex Labo Co. Ltd Recent Developments
  61. 8.11 Berry
  62. 8.11.1 Berry Company Information
  63. 8.11.2 Berry Business Overview
  64. 8.11.3 Berry Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Berry Antiviral Drug Packaging Product Portfolio
  66. 8.11.5 Berry Recent Developments
  67. 8.12 Lageen Tubes.
  68. 8.12.1 Lageen Tubes. Company Information
  69. 8.12.2 Lageen Tubes. Business Overview
  70. 8.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lageen Tubes. Antiviral Drug Packaging Product Portfolio
  72. 8.12.5 Lageen Tubes. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antiviral Drug Packaging Value Chain Analysis
  2. 9.1.1 Antiviral Drug Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antiviral Drug Packaging Production Mode & Process
  6. 9.2 Antiviral Drug Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antiviral Drug Packaging Distributors
  9. 9.2.3 Antiviral Drug Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst